NASDAQ:GPCR

Structure Therapeutics

Stock

USD

Last Close

33.47

06/11 21:01

Market Cap

2.25B

Beta: -

Volume Today

656.36K

Avg: 1.02M

PE Ratio

−22.22

PFCF: −22.62

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '20	Dec '21	Dec '22	Dec '23
net income	-15.88K -	-38.05K 139.66%	-51.32M 134,781.34%	-89.54M 74.47%
depreciation and amortization	20.03K -	72 99.64%	277K 384,622.22%	949.17K 242.66%
deferred income tax	-20.03K -	27 100.13%		860K -
stock based compensation	570 -	1.49K 160.88%	2.51M 168,965.23%	8.19M 225.82%
change in working capital	946 -	4.06K 329.39%	2.97M 72,967.45%	6.96M 134.50%
accounts receivables
inventory
accounts payables	1.02K -	1.90K 85.98%	2.15M 113,394.99%	-859.25K 139.91%
other working capital	-74 -	2.17K 3,025.68%	815K 37,544.34%	7.82M 859.41%
other non cash items	77 -	241 212.99%	-558K 231,635.27%	-6.84M 1,125.26%
net cash provided by operating activities	-14.28K -	-32.16K 125.16%	-46.12M 143,307.96%	-79.42M 72.20%
investments in property plant and equipment	-19 -	-1.21K 6,247.37%	-155K 12,752.40%	-2.17M 1,296.85%
acquisitions net		-19.07K -	61.95K 424.96%
purchases of investments	-21.13K -	-4.21K 80.06%	-123.45M 2,930,882.91%	-416.99M 237.77%
sales maturities of investments		23.28K -	61.50M 264,109.31%	151.05M 145.61%
other investing activites		19.07K -	-61.95K 424.96%
net cash used for investing activites	-21.15K -	17.86K 184.45%	-62.11M 347,868.63%	-268.11M 331.68%
debt repayment
common stock issued	25.88M -	103.39M 299.48%	31.50M 69.54%	472.68M 1,400.80%
common stock repurchased			-5.99K -
dividends paid
other financing activites	-25.86M -	-103.29M 299.48%	-2.48M 97.60%	-21.55M 770.37%
net cash used provided by financing activities	25.84K -	103.25K 299.64%	29.01M 27,999.64%	451.14M 1,454.90%
effect of forex changes on cash				90.14K -
net change in cash	-9.59K -	88.95K 1,027.27%	-79.21M 89,151.52%	103.70M 230.91%
cash at beginning of period	25.95K -	16.35K 36.97%	105.31M 643,888.50%	26.09M 75.22%
cash at end of period	16.35K -	105.31K 543.99%	26.09M 24,676.60%	129.79M 397.46%
operating cash flow	-14.28K -	-32.16K 125.16%	-46.12M 143,307.96%	-79.42M 72.20%
capital expenditure	-19 -	-1.21K 6,247.37%	-155K 12,752.40%	-2.17M 1,296.85%
free cash flow	-14.30K -	-33.37K 133.30%	-46.27M 138,589.08%	-81.58M 76.30%

All numbers in USD (except ratios and percentages)